Penn STEM Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Penn STEM Times.

Press releases published on June 29, 2026

3 hours ago

Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength

Indeterminate GlobeNewswire

3 hours ago

Correction: VivoPower Selects Global AI Industry Leader as Preferred Tenant for Lease of Norway Operational Data Center

Indeterminate GlobeNewswire

4 hours ago

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

Indeterminate GlobeNewswire

4 hours ago

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

Indeterminate GlobeNewswire

4 hours ago

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

Indeterminate GlobeNewswire

4 hours ago

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

Indeterminate GlobeNewswire

4 hours ago

Dyadic Expands IP Protection and Business Development Activities in Japan

Indeterminate GlobeNewswire

4 hours ago

George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations

Indeterminate GlobeNewswire

4 hours ago

Field and Operations Teams Run Daily Work on Custom Power Apps

Indeterminate GlobeNewswire

4 hours ago

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

4 hours ago

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

4 hours ago

Vetty Named a 2026 North American Inspiring Workplace

Indeterminate GlobeNewswire

4 hours ago

Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET

Indeterminate GlobeNewswire

4 hours ago

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

4 hours ago

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire

4 hours ago

NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company

Indeterminate GlobeNewswire

4 hours ago

BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

Indeterminate GlobeNewswire

4 hours ago

Bitdeer Technologies Group Signs Colocation Lease Agreement for Tydal, Norway AI Data Center Site

Indeterminate GlobeNewswire

4 hours ago

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Indeterminate GlobeNewswire

4 hours ago

Aurora Mobile's EngageLab Announces Launch of Silent Auth to Elevate Identity Verification for the Global Market

Indeterminate GlobeNewswire